Skip to main content Skip to main navigation menu Skip to site footer
Short Article
Published: 2021-12-15

Prophylactic use of Ivermectin against COVID-19

FACERES – Medical School of Sao Jose do Rio Preto, Sao Paulo, Brazil
FACERES – Medical School of Sao Jose do Rio Preto, Sao Paulo, Brazil
FACERES – Medical School of Sao Jose do Rio Preto, Sao Paulo, Brazil / Researcher at the Laboratory of Virology at the Faculty of Medicine of Sao Jose do Rio Preto – FAMERP, Sao Jose do Rio Preto, Sao Paulo, Brazil / Professor at Universidade Estadual Paulista "Júlio de Mesquita Filho", Sao Jose do Rio Preto, Sao Paulo, Brazil
Ivermectin COVID-19 Prophylaxis

References

  1. World Health Organization W. Coronavirus disease 2019 (COVID-19) Situation Report – 68 – 28 March 2020. Geneva: World Health Organization; 2020 [Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200328-sitrep-68-covid-19.pdf?sfvrsn=384bc74c_2.
  2. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020:104787.
  3. Guzzo CA, Furtek CI, Porras AG, Chen C, Tipping R, Clineschmidt CM, et al. Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects. 2002;42(10):1122-33.

How to Cite

Ramalho, R. B., Bim, V. M., & Pacca, C. C. M. (2021). Prophylactic use of Ivermectin against COVID-19. MedNEXT Journal of Medical and Health Sciences, 2(6). https://doi.org/10.54448/mdnt21619